# Study of Cemiplimab - TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

> **NCT05376553** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Krzysztof Misiukiewicz** · enrollment: 24 (estimated)

## Conditions studied

- Locally Advanced Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** Cemiplimab
- **DRUG:** Cisplatin
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT05376553
- **Lead sponsor:** Krzysztof Misiukiewicz
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-07-20
- **Primary completion:** 2025-10
- **Final completion:** 2025-10
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05376553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05376553, "Study of Cemiplimab - TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05376553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*